InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Lefebvre Eric, Directeur Médical. Insider active across 1 company, notably Pliant Therapeutics, INC.. In total, 17 reports have been recorded. Breakdown: 0 buy · 10 sells. Total volume traded: €3.9m. History available since 18 June 2021. The latest transaction was disclosed on 23 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
45,650 shares0Common StockSEC:0001746473-25-000013:0
18,478 shares@ US$11.20115.2% of flowCommon StockSEC:0001746473-25-000003:0
12,319 shares@ US$11.563.4% of flowCommon StockSEC:0001746473-24-000129:0
24,063 shares0Common StockSEC:0001746473-24-000119:0
42,900 shares0Common StockSEC:0001746473-24-000017:0
10,295 shares@ US$17.234.2% of flowCommon StockSEC:0001746473-24-000002:0
22,321 shares@ US$18.00919.2% of flowCommon StockSEC:0001209191-23-042831:0
43,750 shares0Common StockSEC:0001209191-23-042660:0
11,245 shares@ US$26.52097.1% of flowCommon StockSEC:0001209191-23-022374:0
21,874 shares0Common StockSEC:0001209191-23-021921:0
57,000 shares0Common StockSEC:0001140361-23-003178:0
67,500 shares@ US$34.483455.3% of flowCommon StockSEC:0001140361-23-002784:0
21,876 shares0Common StockSEC:0001140361-22-046569:0
5,000 shares@ US$25.04823.2% of flowCommon StockSEC:0001209191-22-054747:0
3,000 shares@ US$20.001.5% of flowCommon StockSEC:0001567619-22-013995:0
8,750 shares@ US$28.62155.4% of flowCommon StockSEC:0001209191-21-042577
8,750 shares@ US$28.62150.28% mcap50.0% of flowCommon StockSEC:0001209191-21-042577:0
17 of 17 declarations
About Lefebvre Eric
Eric Lefebvre is the Chief Medical Officer at PLIANT THERAPEUTICS, INC. He is responsible for leading medical initiatives and research. His role is essential in ensuring that the company adheres to medical and ethical standards in its operations.
